← Leaderboards
Joan Siefert Brugge
Dana-Farber Cancer Institute
$26,786,782
Attributed
$26,786,782
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,361,178 · 15
By mechanism
U19$10,574,396 · 1
R01$8,010,514 · 4
R35$7,080,546 · 1
P01$6,512,016 · 4
T32$3,244,480 · 1
U54$1,091,895 · 1
Top collaborators
- Habibul Ahsan5 shared
- Stephen J Chanock5 shared
- Jack Cuzick5 shared
- Douglas Frederick Easton5 shared
- Matthew L Freedman5 shared
- Judy Ellen Garber5 shared
- David E. Goldgar5 shared
- Christopher Alan Haiman5 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Edward J Benz$50,055,526
- Ruth Margrit Ruprecht$54,953,328
- James L M Ferrara$21,206,325
- Richard D Kolodner$25,032,745
- Joseph H Antin$7,618,391
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTumorBreastStructureTumor ProgressionMammary NeoplasmsTissuesTumorigenesisNeoplastic CellCell ProliferationTumor InitiationIn VitroMalignant Breast NeoplasmGenesHistologyMammary GlandBaseBiologicalCollaborationsIn VivoInheritedEpithelial CellsNeoplasm MetastasisReconstitution
Grant awards (73)
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$1,008,464
R35 · FY2025 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$966,150
R35 · FY2024 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$112,480
R35 · FY2024 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$996,660
R35 · FY2023 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$114,535
R35 · FY2023 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$996,660
R35 · FY2022 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$851,597
R35 · FY2021 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$1,017,000
R35 · FY2020 · CA · contact PI
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development$1,017,000
R35 · FY2019 · CA · contact PI
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells$394,740
R01 · FY2018 · CA · contact PI
Breast Tumor Heterogeneity and its Impact on Tumor Progression$342,407
P01 · FY2018 · CA · contact PI
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells$395,654
R01 · FY2017 · CA · contact PI
Breast Tumor Heterogeneity and its Impact on Tumor Progression$341,520
P01 · FY2017 · CA · contact PI
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells$396,541
R01 · FY2016 · CA · contact PI
Breast Tumor Heterogeneity and its Impact on Tumor Progression$340,445
P01 · FY2016 · CA · contact PI
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells$397,851
R01 · FY2015 · CA · contact PI
Breast Tumor Heterogeneity and its Impact on Tumor Progression$340,158
P01 · FY2015 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$574,120
U19 · FY2014 · CA
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells$398,239
R01 · FY2014 · CA · contact PI
Breast Tumor Heterogeneity and its Impact on Tumor Progression$347,697
P01 · FY2014 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,309,806
U19 · FY2013 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal$344,514
P01 · FY2013 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,486,910
U19 · FY2012 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal$367,402
P01 · FY2012 · CA · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$126,750
R01 · FY2012 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,465,094
U19 · FY2011 · CA
Cell Death Regulation in Lumen Formation and Oncogenesis$497,087
R01 · FY2011 · CA · contact PI
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal$368,455
P01 · FY2011 · CA · contact PI
Discovery, Biology and Risk of Inherited Variants in Breast Cancer$2,738,466
U19 · FY2010 · CA
CELLULAR AND DEVELOPMENTAL BIOLOGY$650,616
T32 · FY2010 · GM · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$512,593
R01 · FY2010 · CA · contact PI
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal$383,164
P01 · FY2010 · CA · contact PI
Discovery$245,056
U54 · FY2010 · GM · contact PI
CELLULAR AND DEVELOPMENTAL BIOLOGY$652,711
T32 · FY2009 · GM · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$502,542
R01 · FY2009 · CA · contact PI
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal$384,355
P01 · FY2009 · CA · contact PI
Variation in Receptor Tyrosine Kinases and Breast Cancer Risk$289,586
P50 · FY2009 · CA · contact PI
Discovery$236,377
U54 · FY2009 · GM · contact PI
CELLULAR AND DEVELOPMENTAL BIOLOGY$649,406
T32 · FY2008 · GM · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$486,587
R01 · FY2008 · CA · contact PI
Discovery$243,068
U54 · FY2008 · GM · contact PI
Mechanisms Involved in Mammary Morphogenesis$192,278
P01 · FY2008 · CA · contact PI
Variation in Receptor Tyrosine Kinases and Breast Cancer Risk$169,626
P50 · FY2008 · CA · contact PI
CELLULAR AND DEVELOPMENTAL BIOLOGY$649,406
T32 · FY2007 · GM · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$481,650
R01 · FY2007 · CA · contact PI
Vav GDP/GTP exchange factors in chemotaxis$423,144
P01 · FY2007 · HL · contact PI
Discovery$221,506
U54 · FY2007 · GM · contact PI
Mechanisms Involved in Mammary Morphogenesis$190,432
P01 · FY2007 · CA · contact PI
P-6: Variation in Receptor Tyrosine Kinases and Breast Cancer Risk$162,984
P50 · FY2007 · CA · contact PI
CELLULAR AND DEVELOPMENTAL BIOLOGY$642,341
T32 · FY2006 · GM · contact PI
Vav GDP/GTP exchange factors in chemotaxis$411,071
P01 · FY2006 · HL · contact PI
Cell Death Regulation in Lumen Formation and Oncogenesis$368,274
R01 · FY2006 · CA · contact PI
Mechanisms Involved in Mammary Morphogenesis$179,128
P01 · FY2006 · CA · contact PI
Discovery$145,888
U54 · FY2006 · GM · contact PI
P-6: Variation in Receptor Tyrosine Kinases and Breast Cancer Risk$106,587
P50 · FY2006 · CA · contact PI
Signaling by Adhesion Receptors$12,000
R13 · FY2006 · CA · contact PI
Vav GDP/GTP exchange factors in chemotaxis$411,071
P01 · FY2005 · HL
Cell Death Regulation in Lumen Formation and Oncogenesis$377,138
R01 · FY2005 · CA
Mechanisms Involved in Mammary Morphogenesis$173,909
P01 · FY2005 · CA
P-6: Variation in Receptor Tyrosine Kinases and Breast Cancer Risk$106,548
P50 · FY2005 · CA
Vav GDP/GTP exchange factors in chemotaxis$411,071
P01 · FY2004 · HL
Cell Death Regulation in Lumen Formation and Oncogenesis$372,466
R01 · FY2004 · CA
Mechanisms Involved in Mammary Morphogenesis$148,724
P01 · FY2004 · CA
Vav GDP/GTP exchange factors in chemotaxis$411,071
P01 · FY2003 · HL
Cell Death Regulation in Lumen Formation and Oncogenesis$374,357
R01 · FY2003 · CA
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINS$300,000
R01 · FY2003 · CA
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINS$466,630
R01 · FY2002 · CA
Targets for intervention in breast cancer$0
P50 · FY2002 · CA
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINS$460,122
R01 · FY2001 · CA
Targets for intervention in breast cancer$0
P50 · FY2001 · CA
SIGNAL TRANSDUCTION EVENTS REGULATED BY INTEGRINS$429,419
R01 · FY2000 · CA
FUNCTIONAL STUDIES OF THE SRC PROTEIN$271,874
R01 · FY2000 · CA
Targets for intervention in breast cancer$0
P50 · FY2000 · CA